Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: AstraZeneca PLC

Market Cap 272B 237B 219B 205B 385B 25,621B 387B 2,601B 1,008B 12,611B 1,019B 997B 43,788B P/E 2026 *
21.9x
P/E 2027 * 19.1x
Enterprise Value 291B 254B 235B 220B 412B 27,437B 415B 2,786B 1,080B 13,505B 1,091B 1,068B 46,892B EV / Sales 2026 *
4.59x
EV / Sales 2027 * 4.22x
Free-Float
96.63%
Yield 2026 *
1.91%
Yield 2027 * 2.01%
1 day+0.61%
1 week-1.69%
Current month-4.12%
1 month-5.51%
3 months-4.76%
6 months-3.20%
Current year-4.03%
1 week 11,484
Extreme 11484
15,126
1 month 11,232
Extreme 11232
15,126
Current year 11,232
Extreme 11232
15,732
1 year 10,103
Extreme 10103
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,680
Extreme 3680
15,732
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Chief Operating Officer 55 01/06/2015
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Date Insider Type Main position Quantity % Market Cap.
06-08Free

See Remarks

1 0.0000%
05-20Sell

See Remarks

-11,893 0.0008%
05-14Fiscal year

Chief Executive Officer

18,359 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
+0.61%-1.69%+27.35%+14.22% 272B
-1.21%-3.04%+44.03%+142.51% 980B
-2.48%-5.18%+52.47%+39.36% 550B
-2.14%-4.94%+16.83%+58.18% 382B
+0.25%-3.09%+23.33%+16.78% 316B
+0.22%-3.10%+24.67%+30.69% 268B
+4.59%+1.98%-38.43%-46.41% 199B
-1.19%-4.95%+16.68%+48.70% 182B
-1.35%-1.46%+14.06%+59.46% 154B
-2.74%-3.82%+5.17%-35.19% 144B
Average -0.54%-3.08%+18.62%+32.83% 344.6B
Weighted average by Cap. -0.86%-3.68%+28.47%+59.38%

Financials

2026 *2027 *
Net sales 63.32B 55.21B 51.13B 47.87B 89.77B 5,975B 90.31B 607B 235B 2,941B 238B 233B 10,212B 67.16B 58.55B 54.23B 50.77B 95.21B 6,337B 95.79B 643B 249B 3,119B 252B 247B 10,830B
Net income 12.49B 10.89B 10.08B 9.44B 17.7B 1,178B 17.81B 120B 46.37B 580B 46.88B 45.87B 2,014B 14.14B 12.33B 11.42B 10.69B 20.04B 1,334B 20.16B 135B 52.49B 657B 53.07B 51.93B 2,280B
Net Debt 19.25B 16.78B 15.54B 14.55B 27.28B 1,816B 27.45B 184B 71.45B 894B 72.24B 70.69B 3,104B 12.01B 10.47B 9.69B 9.08B 17.02B 1,133B 17.12B 115B 44.57B 558B 45.06B 44.1B 1,936B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
19/06/26 13,234.00 p +0.61% 4,448,738
18/06/26 13,154.00 p -2.36% 1,591,360
17/06/26 13,472.00 p +1.42% 1,420,705
16/06/26 13,284.00 p +0.64% 4,260,905
15/06/26 13,200.00 p -1.95% 1,818,098
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
175.07USD
Average target price
221.03USD
Spread / Average Target
+26.26%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!